本校學位論文庫
CITYU Theses & Dissertations
論文詳情
肖雪
陳侃
大健康學院
應用心理學博士學位課程
博士
2023
意象體現療法對急性冠脈綜合征合併抑鬱患者的身心干預
Psychosomatic intervention of Embodied Imagination therapy for patients with acute coronary syndrome complicated with depression
急性冠脈綜合征 ; 意象體現治療 ; 抑鬱 ; 生活品質 ; 心率變異性 ; 心血管事件
acute coronary syndrome ; Embodied Imagination therapy ; depression ; quality of life ; heart rate variability ; cardiovascular event
公開日期：2/1/2026
本研究目的在於探索短程意象體現技術在急性冠脈綜合征合併抑鬱患者治療中的臨床應用，評估其對患者情緒、軀體伴隨症狀及生活品質的改善效果，旨在探索心身疾病患者有效的心理幹預模式。
本研究通過隨機對照實驗和個案分析方法進行兩方面的研究：研究一通過隨機對照實驗設計，連續入選 2020 年 9月至 2022 年 3 月在北京兩家三甲醫院心內科門診就診的急性冠脈綜合征合併輕中度抑鬱患者,隨機分為意象體現組(30例)和藥物組(30 例)。意象體現組在常規心內科藥物治療的基礎上,給予個體意象體現治療8周，每次60分鐘，每週一次。藥物組在常規心內科治療的基礎上, 給予抗抑鬱藥舍曲林口服治療。分別於治療前，治療4周、8週末後，以及24週末隨訪時，採用漢密爾頓抑鬱量表(HAMD-17)、漢密爾頓焦慮量表（HAMA）、西雅圖心絞痛量表(SAQ)、醫學應對問卷(MCMQ)進行評估，檢測心率變異性（HRV）,同時記錄不良反應及不良心血管事件。統計分析比較組間及組內的差異，驗證意象體現治療模式對急性冠脈綜合征患者的心身療效，檢驗療效是否不劣於抗抑鬱藥舍曲林，同時分析其優勢治療維度。研究二採用個案分析的方法進行研究，搜集過程資料，深入探討意象體現治療模式的改變機制。
研究結果：
1.意象體現治療能夠改善急性冠脈綜合征合併抑鬱患者的抑鬱、焦慮,失眠以及伴隨的軀體不適症狀。研究顯示在治療早期（治療4週末）抗抑鬱藥物治療起效更快，藥物短期療效優於意象體現治療。但在治療結束（治療8週末），及半年後隨訪時，兩組患者在抑鬱、焦慮及伴隨症狀的改善上無明顯差異。
2.統計分析西雅圖心絞痛量表五個維度的評分，在幹預 4周、8周及24周隨訪時兩組患者的軀體活動受限程度、心絞痛穩定狀態、心絞痛的發作頻率、治療的滿意程度及疾病認知五個維度的評分均有所升高，進一步比較發現，意象體現組在疾病認知維度，在幹預4周、8周及24周隨訪時評分均高於藥物組，有統計學差異。意象體現治療和抗抑鬱藥物治療都能在緩解情緒的同時，改善急性冠脈綜合征患者的機能狀態和生活品質。且意象體現組患者在疾病認知維度的效果要顯著優於藥物組。
3.意象體現治療能夠讓患者減少消極應對疾病，更多的採取面對疾病的應對方式，有利於疾病的預後。經過8周治療，意象體現組“回避”應對方式比藥物組顯著減少，“面對”應對方式比藥物組顯著增加。這種差異在半年後隨訪時仍然存在。
4.與基線比較，患者經意象體現治療4周後，心率變異性無顯著性變化，但8週末及半年隨訪時SDNN、SDANN、RMSSD、PNN50值顯著升高，LF值顯著減低，與藥物組變化趨勢基本一致，表明兩種幹預方式對急性冠脈綜合征患者心率變異性的影響相似。
5.以8週末HAMD-17量表評分進行非劣效性檢驗，非劣效性界值為3.2，差異有統計學意義，意象體現治療對急性冠脈綜合征合併抑鬱患者抗抑鬱療效不劣於抗抑鬱藥。
6.兩組再次血運重建、非致死心肌梗死、心力衰竭、總體心血管事件組間比較均無統計學差異。
研究結論：
1.意象體現治療對於急性冠脈綜合征合併抑鬱患者有確切幹預效果，且療效不劣於常用抗抑鬱藥物舍曲林。均能在緩解患者情緒問題的同時，改善急性冠脈綜合征患者預後，降低不良心血管事件的發生，提高患者機能狀態及生活品質。意象體現治療能夠對治病的深層心理因素起到幹預效果，減少患者“回避”應對，同時可能通過影響患者下丘腦—垂體—腎上腺素軸（HPA）自律性的喚醒，進而影響心臟交感和副交感神經的張力，從而發揮身心共愈的治療效果，從而影響冠脈綜合征患者的遠期預後。
2. 個案分析表明意象體現治療的治癒路徑及改變機制：首先讓個案確認身體的不適感，辨別症狀的心臟和心理來源。選擇患者覺得與軀體症狀有關的重要夢境進行工作，通過視角轉換技術，夢者擴展了慣常的執著的“我”，治療中從非慣性的視角獲得更多的體驗。另外隨著意象的湧現，過往經驗被喚醒，回憶起壓抑在身體的記憶，通過多重身體感受的對比和整合形成新的記憶，對創傷身體記憶進行化解，實現心身療愈的效果。
本研究通過隨機對照實驗和個案分析方法進行兩方面的研究：研究一通過隨機對照實驗設計，連續入選 2020 年 9月至 2022 年 3 月在北京兩家三甲醫院心內科門診就診的急性冠脈綜合征合併輕中度抑鬱患者,隨機分為意象體現組(30例)和藥物組(30 例)。意象體現組在常規心內科藥物治療的基礎上,給予個體意象體現治療8周，每次60分鐘，每週一次。藥物組在常規心內科治療的基礎上, 給予抗抑鬱藥舍曲林口服治療。分別於治療前，治療4周、8週末後，以及24週末隨訪時，採用漢密爾頓抑鬱量表(HAMD-17)、漢密爾頓焦慮量表（HAMA）、西雅圖心絞痛量表(SAQ)、醫學應對問卷(MCMQ)進行評估，檢測心率變異性（HRV）,同時記錄不良反應及不良心血管事件。統計分析比較組間及組內的差異，驗證意象體現治療模式對急性冠脈綜合征患者的心身療效，檢驗療效是否不劣於抗抑鬱藥舍曲林，同時分析其優勢治療維度。研究二採用個案分析的方法進行研究，搜集過程資料，深入探討意象體現治療模式的改變機制。
研究結果：
1.意象體現治療能夠改善急性冠脈綜合征合併抑鬱患者的抑鬱、焦慮,失眠以及伴隨的軀體不適症狀。研究顯示在治療早期（治療4週末）抗抑鬱藥物治療起效更快，藥物短期療效優於意象體現治療。但在治療結束（治療8週末），及半年後隨訪時，兩組患者在抑鬱、焦慮及伴隨症狀的改善上無明顯差異。
2.統計分析西雅圖心絞痛量表五個維度的評分，在幹預 4周、8周及24周隨訪時兩組患者的軀體活動受限程度、心絞痛穩定狀態、心絞痛的發作頻率、治療的滿意程度及疾病認知五個維度的評分均有所升高，進一步比較發現，意象體現組在疾病認知維度，在幹預4周、8周及24周隨訪時評分均高於藥物組，有統計學差異。意象體現治療和抗抑鬱藥物治療都能在緩解情緒的同時，改善急性冠脈綜合征患者的機能狀態和生活品質。且意象體現組患者在疾病認知維度的效果要顯著優於藥物組。
3.意象體現治療能夠讓患者減少消極應對疾病，更多的採取面對疾病的應對方式，有利於疾病的預後。經過8周治療，意象體現組“回避”應對方式比藥物組顯著減少，“面對”應對方式比藥物組顯著增加。這種差異在半年後隨訪時仍然存在。
4.與基線比較，患者經意象體現治療4周後，心率變異性無顯著性變化，但8週末及半年隨訪時SDNN、SDANN、RMSSD、PNN50值顯著升高，LF值顯著減低，與藥物組變化趨勢基本一致，表明兩種幹預方式對急性冠脈綜合征患者心率變異性的影響相似。
5.以8週末HAMD-17量表評分進行非劣效性檢驗，非劣效性界值為3.2，差異有統計學意義，意象體現治療對急性冠脈綜合征合併抑鬱患者抗抑鬱療效不劣於抗抑鬱藥。
6.兩組再次血運重建、非致死心肌梗死、心力衰竭、總體心血管事件組間比較均無統計學差異。
研究結論：
1.意象體現治療對於急性冠脈綜合征合併抑鬱患者有確切幹預效果，且療效不劣於常用抗抑鬱藥物舍曲林。均能在緩解患者情緒問題的同時，改善急性冠脈綜合征患者預後，降低不良心血管事件的發生，提高患者機能狀態及生活品質。意象體現治療能夠對治病的深層心理因素起到幹預效果，減少患者“回避”應對，同時可能通過影響患者下丘腦—垂體—腎上腺素軸（HPA）自律性的喚醒，進而影響心臟交感和副交感神經的張力，從而發揮身心共愈的治療效果，從而影響冠脈綜合征患者的遠期預後。
2. 個案分析表明意象體現治療的治癒路徑及改變機制：首先讓個案確認身體的不適感，辨別症狀的心臟和心理來源。選擇患者覺得與軀體症狀有關的重要夢境進行工作，通過視角轉換技術，夢者擴展了慣常的執著的“我”，治療中從非慣性的視角獲得更多的體驗。另外隨著意象的湧現，過往經驗被喚醒，回憶起壓抑在身體的記憶，通過多重身體感受的對比和整合形成新的記憶，對創傷身體記憶進行化解，實現心身療愈的效果。
Objective：
This study examines how short-course Embodied Imagination therapy is used to treat acute coronary syndrome patients paired with depression in a clinical setting, as well as to determine whether it improves patients' mood, their somatic symptoms and their quality of life, with the aim of exploring effective psychological intervention models for those suffering from psychosomatic conditions.
Methods：
1. There were a total of 30 patients in Study 1 who, between September 2020 and March 2022, attended outpatient clinics of cardiology departments at two hospitals in Beijing with acute coronary syndrome and mild to moderate depression. They were randomly assigned to either the Embodied Imagination treatment group (30 cases) or the medication treatment group (30 cases) based on the results of a randomized, controlled, non-inferiority experimental design. Embodied imagination was given to patients in the Embodied Imagination group, along with conventional cardiology medication, for eight weeks, twice a week, in addition to conventional cardiology treatment. In the drug group, the antidepressant sertraline was given orally in addition to the conventional cardiology treatment. The Hamilton Depression Scale (HAMD-17), Hamilton Anxiety Inventory (HAMA), Seattle Angina Scale (SAQ), and Medical Coping Questionnaire (MCMQ) were used for assessment before treatment, after 4 and 8 weeks of treatment, and at the follow-up visit at the end of 24 weeks, respectively, to detect heart rate variability (HRV), and to record adverse effects and cardiovascular events. Statistical analysis was used to compare the differences between groups and within groups, to verify the psychosomatic efficacy of Imagery Embodiment therapy in patients with acute coronary syndrome, to test whether the efficacy was not inferior to the antidepressant sertraline, and to analyze its superior treatment dimension.
2. Using a case study approach to collect process data and to investigate in depth the mechanism of change in the Embodied Imagination therapy model.
Results：
1. Embodied Imagination treatment improved depression, anxiety, insomnia, and concomitant somatic symptoms in patients with acute coronary syndrome combined with depression. The study showed that antidepressant medication had a faster onset of action early in treatment (at the end of 4 weeks of treatment) and that the short-term efficacy of the medication was better than that of Embodied Imagination treatment. However, at the end of treatment (8 weekends of treatment) and at the six-month follow-up, there was no significant difference in the improvement of depression, anxiety, and concomitant symptoms between the two groups.
2. Statistical analysis of the scores of the five dimensions of the Seattle Angina Scale showed that the scores of the five dimensions of limitation of physical activity, stable state of angina, frequency of angina attacks, satisfaction with treatment and disease perception increased in both groups at 4 weeks, 8 weeks and 24 weeks follow-up of the intervention, and further comparison revealed that the Embodied Imagination group had higher scores in the disease perception dimension, at The scores at 4 weeks, 8 weeks and 24 weeks follow-up of the intervention were statistically higher in the Embodied Imagination group than in the drug group. Both Embodied Imagination treatment and antidepressant treatment improved functional status and quality of life in patients with acute coronary syndrome while relieving mood. Patients in the Embodied Imagination group had significantly better outcomes than the medication group in the disease perception dimension.
3. Embodied Imagination treatment can help patients to cope with the disease less negatively and more confrontation with the disease, which is beneficial to the prognosis of the disease. After 8 weeks of treatment, the Embodied Imagination group showed a significant decrease in "avoidance" coping and a significant increase in "confrontation" coping compared to the medication group. This difference persisted at the six-month follow-up.
4.Compared with baseline, there was no significant change on heart rate variability(HRV) after 4 weeks of Embodied Imagination treatment . However, the values of SDNN, SDANN, RMSSD, PNN50 were significantly higher at the end of 8 weeks and at the six-month follow-up, and the LF value decreased significantly , which were generally consistent with the trend of the drug group, indicating that both interventions had similar effects on heart rate variability in patients with acute coronary syndrome. The effects of both interventions on HRV in patients with acute coronary syndrome were similar.
5.The non-inferiority test with the HAMD-17 scale score at the end of 8 weeks showed a non-inferiority threshold of 3.2, which was statistically significant, and the antidepressant efficacy of Embodied Imagination was not inferior to that of antidepressants in patients with acute coronary syndrome combined with depression.
6. There was no statistically significant difference between the two groups in terms of re-vascularization, non-fatal myocardial infarction, heart failure, and overall cardiovascular events.
Conclusion:
Embodied Imagination treatment has a definite intervention effect on patients with acute coronary syndrome combined with depression, and the efficacy is not inferior to antidepressant medication. Embodied Imagination treatment can improve the prognosis of patients with acute coronary syndrome, reduce the incidence of cardiovascular events, and improve the functional status and quality of life of patients while alleviating their emotional problems. Embodied Imagination treatment can interfere with the deep psychological factors of the treatment, reduce the patient's "avoidance" response, and may affect the long-term prognosis of patients with coronary syndromes by influencing the arousal of the autonomic hypothalamic-pituitary-adrenergic axis (HPA), which in turn affects the sympathetic and parasympathetic tone of the heart.
Through a detailed analysis of the short course of Embodied Imagination, we explore the healing path and alters mechanisms of psychotherapy for psychosomatic disorders. In the treatment, the case is first asked to identify the physical discomfort and to identify the cardiac and psychological sources of the symptoms. Through the perspective-shifting technique, the dreamer expands the usual obsessive "I" and has more experience from a non-dominant perspective in the treatment. In addition, with the emergence of imagery, past experiences are awakened, memories repressed in the body are recalled, and new memories are formed by comparing and integrating multiple bodily sensations, and traumatic bodily memories are dissolved. The body, as a mind-body network, becomes a holding place for spiritual materials, constantly adapting to its surroundings, making adjustments, and achieving mind-body healing effects.
This study examines how short-course Embodied Imagination therapy is used to treat acute coronary syndrome patients paired with depression in a clinical setting, as well as to determine whether it improves patients' mood, their somatic symptoms and their quality of life, with the aim of exploring effective psychological intervention models for those suffering from psychosomatic conditions.
Methods：
1. There were a total of 30 patients in Study 1 who, between September 2020 and March 2022, attended outpatient clinics of cardiology departments at two hospitals in Beijing with acute coronary syndrome and mild to moderate depression. They were randomly assigned to either the Embodied Imagination treatment group (30 cases) or the medication treatment group (30 cases) based on the results of a randomized, controlled, non-inferiority experimental design. Embodied imagination was given to patients in the Embodied Imagination group, along with conventional cardiology medication, for eight weeks, twice a week, in addition to conventional cardiology treatment. In the drug group, the antidepressant sertraline was given orally in addition to the conventional cardiology treatment. The Hamilton Depression Scale (HAMD-17), Hamilton Anxiety Inventory (HAMA), Seattle Angina Scale (SAQ), and Medical Coping Questionnaire (MCMQ) were used for assessment before treatment, after 4 and 8 weeks of treatment, and at the follow-up visit at the end of 24 weeks, respectively, to detect heart rate variability (HRV), and to record adverse effects and cardiovascular events. Statistical analysis was used to compare the differences between groups and within groups, to verify the psychosomatic efficacy of Imagery Embodiment therapy in patients with acute coronary syndrome, to test whether the efficacy was not inferior to the antidepressant sertraline, and to analyze its superior treatment dimension.
2. Using a case study approach to collect process data and to investigate in depth the mechanism of change in the Embodied Imagination therapy model.
Results：
1. Embodied Imagination treatment improved depression, anxiety, insomnia, and concomitant somatic symptoms in patients with acute coronary syndrome combined with depression. The study showed that antidepressant medication had a faster onset of action early in treatment (at the end of 4 weeks of treatment) and that the short-term efficacy of the medication was better than that of Embodied Imagination treatment. However, at the end of treatment (8 weekends of treatment) and at the six-month follow-up, there was no significant difference in the improvement of depression, anxiety, and concomitant symptoms between the two groups.
2. Statistical analysis of the scores of the five dimensions of the Seattle Angina Scale showed that the scores of the five dimensions of limitation of physical activity, stable state of angina, frequency of angina attacks, satisfaction with treatment and disease perception increased in both groups at 4 weeks, 8 weeks and 24 weeks follow-up of the intervention, and further comparison revealed that the Embodied Imagination group had higher scores in the disease perception dimension, at The scores at 4 weeks, 8 weeks and 24 weeks follow-up of the intervention were statistically higher in the Embodied Imagination group than in the drug group. Both Embodied Imagination treatment and antidepressant treatment improved functional status and quality of life in patients with acute coronary syndrome while relieving mood. Patients in the Embodied Imagination group had significantly better outcomes than the medication group in the disease perception dimension.
3. Embodied Imagination treatment can help patients to cope with the disease less negatively and more confrontation with the disease, which is beneficial to the prognosis of the disease. After 8 weeks of treatment, the Embodied Imagination group showed a significant decrease in "avoidance" coping and a significant increase in "confrontation" coping compared to the medication group. This difference persisted at the six-month follow-up.
4.Compared with baseline, there was no significant change on heart rate variability(HRV) after 4 weeks of Embodied Imagination treatment . However, the values of SDNN, SDANN, RMSSD, PNN50 were significantly higher at the end of 8 weeks and at the six-month follow-up, and the LF value decreased significantly , which were generally consistent with the trend of the drug group, indicating that both interventions had similar effects on heart rate variability in patients with acute coronary syndrome. The effects of both interventions on HRV in patients with acute coronary syndrome were similar.
5.The non-inferiority test with the HAMD-17 scale score at the end of 8 weeks showed a non-inferiority threshold of 3.2, which was statistically significant, and the antidepressant efficacy of Embodied Imagination was not inferior to that of antidepressants in patients with acute coronary syndrome combined with depression.
6. There was no statistically significant difference between the two groups in terms of re-vascularization, non-fatal myocardial infarction, heart failure, and overall cardiovascular events.
Conclusion:
Embodied Imagination treatment has a definite intervention effect on patients with acute coronary syndrome combined with depression, and the efficacy is not inferior to antidepressant medication. Embodied Imagination treatment can improve the prognosis of patients with acute coronary syndrome, reduce the incidence of cardiovascular events, and improve the functional status and quality of life of patients while alleviating their emotional problems. Embodied Imagination treatment can interfere with the deep psychological factors of the treatment, reduce the patient's "avoidance" response, and may affect the long-term prognosis of patients with coronary syndromes by influencing the arousal of the autonomic hypothalamic-pituitary-adrenergic axis (HPA), which in turn affects the sympathetic and parasympathetic tone of the heart.
Through a detailed analysis of the short course of Embodied Imagination, we explore the healing path and alters mechanisms of psychotherapy for psychosomatic disorders. In the treatment, the case is first asked to identify the physical discomfort and to identify the cardiac and psychological sources of the symptoms. Through the perspective-shifting technique, the dreamer expands the usual obsessive "I" and has more experience from a non-dominant perspective in the treatment. In addition, with the emergence of imagery, past experiences are awakened, memories repressed in the body are recalled, and new memories are formed by comparing and integrating multiple bodily sensations, and traumatic bodily memories are dissolved. The body, as a mind-body network, becomes a holding place for spiritual materials, constantly adapting to its surroundings, making adjustments, and achieving mind-body healing effects.
2023
中文
192
致 謝 I
摘 要 III
Abstract VII
圖目錄 XVI
表目錄 XVII
第一章 緒 論 1
1.1 研究背景及意義 1
1.2 研究目的 7
第二章 “雙心”理論的研究與綜述 9
2.1 “雙心”概念的起源 10
2.2 中國傳統文化視角下的“雙心”關係 11
2.2.1 儒家的心 13
2.2.2 道家的心 15
2.2.3 佛家的心 16
2.3 傳統中醫視角下的“雙心”理論 17
2.4 精神動力學視角下的“雙心”理論 20
第三章 ACS患者的心理社會因素 26
3.1 ACS的概念及診斷 26
3.2 ACS患者的心理應激 27
3.3 急性冠脈綜合征與抑鬱 28
3.3.1 ACS與抑鬱的相關性 28
3.3.2 ACS患者抑鬱的識別、篩查與評估 30
3.4 ACS與D型人格 33
第四章 ACS共病抑鬱的機制及治療 36
4.1 ACS共病抑鬱的機制 36
4.1.1 ACS共病抑鬱的生物學機制 36
4.1.2 ACS中醫的病因病機 39
4.2 ACS共病抑鬱的治療 40
4.2.1 西醫治療 40
4.2.2 心理治療 41
第五章 夢工作理論與應用的實證研究綜述 45
5.1經典精神分析取向的釋夢觀點 45
5.1.1 佛洛伊德的釋夢觀點 45
5.1.2 榮格的釋夢觀點 46
5.1.3 阿德勒的釋夢觀點 49
5.2 現代心理學的夢工作方法 51
5.2.1 Johnson的釋夢方法 51
5.2.2 Ullman的夢工作方法 52
5.2.3 Hill的夢工作方法 52
5.3 夢在心理治療中應用的相關研究 53
5.3.1 夢的意義及在心理治療中的作用 53
5.3.2 夢的內容與心理疾病和心身疾病的關係 55
5.3.3 夢的工作方法和療效的實證研究 57
第六章 意象體現技術對ACS合併抑鬱治療的隨機對照研究 59
6.1 意象體現技術對ACS合併抑鬱患者治療理論及框架 59
6.1.1 意象體現技術的簡介及操作方法 59
6.1.2 短程意象體現技術對雙心疾病患者的治療路徑 67
6.1.3 意象體現技術對心身疾病的治療原理 69
6.2 研究方法 73
6.2.1 研究物件 74
6.2.2 評估方法 76
6.2.3 實施方案 78
6.2.4 結果評估 80
6.2.5 統計分析方法 82
6.2.6 品質控制 83
6.2.7 擬採取的具體步驟 83
6.2.8 技術路線圖 84
6.3 研究結果 85
6.3.1 基線臨床資料比較 85
6.3.2 療效分析 87
6.3.2.1 HAMD-17評分的比較 88
6.3.2.2 HAMA評分的比較 95
6.3.2.3 PSQI評分的比較 100
6.3.2.4 SAQ評分的比較 102
6.3.3 應對方式變化的比較 111
6.3.4 心率變異性指標的比較 115
6.3.5 臨床有效率的比較 117
6.3.6 非劣效性檢驗 117
6.3.7 安全性分析 118
6.3.8 心血管事件比較 119
6.3.9 小結 119
6.4 討論 123
6.4.1 意象體現治療對ACS合併抑鬱患者抑鬱及伴隨症狀的影響 124
6.4.2 意象體現治療對ACS合併抑鬱患者生活品質的影響 125
6.4.3 意象體現治療對ACS合併抑鬱患者應對方式的影響 126
6.4.4 意象體現治療對ACS合併抑鬱患者心率變異的影響 127
第七章 意象體現技術對ACS合併抑鬱治療的個案研究 131
7.1 個案基本情況 131
7.2 評估、分析與診斷 135
7.3 目標與計畫 136
7.3.1 諮詢目標 136
7.3.2 諮詢計畫 137
7.4 諮詢過程 137
7.4.1 初始訪談、身體感覺的探索與症狀澄清 138
7.4.2 知己知彼，有的放矢 139
7.4.3 初始夢的工作 141
7.4.4 噩夢的工作 144
7.4.5 夢境轉變，水利萬物，獲得力量 149
7.5 討論 153
第八章 研究結論、不足與展望 155
8.1 研究結論 155
8.2 研究不足 156
8.3 研究展望 156
參考文獻 158
作者簡歷 174
附 錄 176
摘 要 III
Abstract VII
圖目錄 XVI
表目錄 XVII
第一章 緒 論 1
1.1 研究背景及意義 1
1.2 研究目的 7
第二章 “雙心”理論的研究與綜述 9
2.1 “雙心”概念的起源 10
2.2 中國傳統文化視角下的“雙心”關係 11
2.2.1 儒家的心 13
2.2.2 道家的心 15
2.2.3 佛家的心 16
2.3 傳統中醫視角下的“雙心”理論 17
2.4 精神動力學視角下的“雙心”理論 20
第三章 ACS患者的心理社會因素 26
3.1 ACS的概念及診斷 26
3.2 ACS患者的心理應激 27
3.3 急性冠脈綜合征與抑鬱 28
3.3.1 ACS與抑鬱的相關性 28
3.3.2 ACS患者抑鬱的識別、篩查與評估 30
3.4 ACS與D型人格 33
第四章 ACS共病抑鬱的機制及治療 36
4.1 ACS共病抑鬱的機制 36
4.1.1 ACS共病抑鬱的生物學機制 36
4.1.2 ACS中醫的病因病機 39
4.2 ACS共病抑鬱的治療 40
4.2.1 西醫治療 40
4.2.2 心理治療 41
第五章 夢工作理論與應用的實證研究綜述 45
5.1經典精神分析取向的釋夢觀點 45
5.1.1 佛洛伊德的釋夢觀點 45
5.1.2 榮格的釋夢觀點 46
5.1.3 阿德勒的釋夢觀點 49
5.2 現代心理學的夢工作方法 51
5.2.1 Johnson的釋夢方法 51
5.2.2 Ullman的夢工作方法 52
5.2.3 Hill的夢工作方法 52
5.3 夢在心理治療中應用的相關研究 53
5.3.1 夢的意義及在心理治療中的作用 53
5.3.2 夢的內容與心理疾病和心身疾病的關係 55
5.3.3 夢的工作方法和療效的實證研究 57
第六章 意象體現技術對ACS合併抑鬱治療的隨機對照研究 59
6.1 意象體現技術對ACS合併抑鬱患者治療理論及框架 59
6.1.1 意象體現技術的簡介及操作方法 59
6.1.2 短程意象體現技術對雙心疾病患者的治療路徑 67
6.1.3 意象體現技術對心身疾病的治療原理 69
6.2 研究方法 73
6.2.1 研究物件 74
6.2.2 評估方法 76
6.2.3 實施方案 78
6.2.4 結果評估 80
6.2.5 統計分析方法 82
6.2.6 品質控制 83
6.2.7 擬採取的具體步驟 83
6.2.8 技術路線圖 84
6.3 研究結果 85
6.3.1 基線臨床資料比較 85
6.3.2 療效分析 87
6.3.2.1 HAMD-17評分的比較 88
6.3.2.2 HAMA評分的比較 95
6.3.2.3 PSQI評分的比較 100
6.3.2.4 SAQ評分的比較 102
6.3.3 應對方式變化的比較 111
6.3.4 心率變異性指標的比較 115
6.3.5 臨床有效率的比較 117
6.3.6 非劣效性檢驗 117
6.3.7 安全性分析 118
6.3.8 心血管事件比較 119
6.3.9 小結 119
6.4 討論 123
6.4.1 意象體現治療對ACS合併抑鬱患者抑鬱及伴隨症狀的影響 124
6.4.2 意象體現治療對ACS合併抑鬱患者生活品質的影響 125
6.4.3 意象體現治療對ACS合併抑鬱患者應對方式的影響 126
6.4.4 意象體現治療對ACS合併抑鬱患者心率變異的影響 127
第七章 意象體現技術對ACS合併抑鬱治療的個案研究 131
7.1 個案基本情況 131
7.2 評估、分析與診斷 135
7.3 目標與計畫 136
7.3.1 諮詢目標 136
7.3.2 諮詢計畫 137
7.4 諮詢過程 137
7.4.1 初始訪談、身體感覺的探索與症狀澄清 138
7.4.2 知己知彼，有的放矢 139
7.4.3 初始夢的工作 141
7.4.4 噩夢的工作 144
7.4.5 夢境轉變，水利萬物，獲得力量 149
7.5 討論 153
第八章 研究結論、不足與展望 155
8.1 研究結論 155
8.2 研究不足 156
8.3 研究展望 156
參考文獻 158
作者簡歷 174
附 錄 176
1.程蒙(2012) 。佛洛伊德與榮格心身學說的比較研究。未出版博（碩）士論文，華中師範大學，武漢。
2.蔡琴鳳、李曉駟（2010）。 夢的內容分析理論研究進展。安徽醫學，31(6)，687-689。
3.陳光磊、黃濟民(2006)。混沌理論對心理諮詢與治療的啟示。教育評論(3),3。
4.陳侃（譯）（2007）。探索夢的原野。廣州：廣東教育出版社（Bosnak, R., 1996）。
5.陳侃(2012)。現代人的心理危機及其幹預的心理分析。上海：上海三聯書店。
6.陳侃（2013）。意象體現與物化體驗。意象體現與中國文化（188–208 頁），廣州：洗心島出版社。
7.車文博（2004）。佛洛伊德·精神分析導論。長春：長春出版社。
8.陳韜、姚祖培（2014）。姚祖培教授辨治“雙心”疾病經驗。中醫藥通報13（1），35-36。
9.笛卡爾（1997）。哲學著作。巴黎：伽爾尼耶出版社。
10.杜瑞霞（2013）．夢的研究進展．語文學刊(6)，76-77，98。
11.馮川（譯）（1987）。榮格心理學入門。上海：上海三聯書店。（霍爾·諾貝德，1987）。
12.馮強、趙旭東(2011)。精神動力學心理治療的效果。上海精神醫學(05)，307-311。
13.高春申（譯）（2013）。夢的解析。北京：中華書局。（Freud, S., 1900）。
14.胡大一（2006）。心血管疾病和精神心理障礙的綜合管理——“雙心醫學”模式的探索。中國臨床醫生34（5），2-3。
15.胡孚深、呂錫（1999）。探道學通論。北京：社會科學文獻出版社。
16.胡孚深、呂錫深（1999）。道學通論(道家道教仙學)。北京：社會科學文獻出版社。
17.李曉紅、張巍、趙明、張紅斌(2011)。冠心病合併不同程度抑鬱患者心率變異性分析。中國心血管雜誌(06)，425-427。
18.李小平(2006)。混沌理論的心理治療觀。南京師大學報(社會科學版)(01)，103-106。
19.羅建平 (1996)。無意識心理學與中醫精神學。醫古文知識(02)，8-10。
20.劉韻涵（譯）（1988）。榮格分析心理學導論。瀋陽：遼寧人民出版。 （弗爾達姆）。
21.呂偉紅(2010)。比較分析佛洛伊德和榮格的釋夢。學術交流(10), 18-21.
22.樸順天（2002）。心神理論研究。未出版博士論文，北京中醫藥大學，北京。
23.申荷永（2001）。中國文化心理學心要。北京：人民出版社。
24.申荷永（2004）。榮格與分析心理學。廣州：廣東高等教育出版。
25.申荷永（2011）。 洗心島之夢。廣州：廣東科技出版社。
26.申荷永（2013）。意象體現與中國文化。廣州：洗心島出版社。
27.申荷永、高嵐（譯）（2014）。榮格文集Ⅳ/Ⅴ（夢的分析）。長春：長春出版社。（Jung, C. G.）。
28.世界中醫藥聯合會心血管病專業委員會、中國中西醫結合學會心血管病專業委員會、中華中醫藥學會介入心臟病學會、國家中醫心血管病臨床醫學研究中心（2020）。冠狀動脈血運重建術後心絞痛中西醫結合診療指南。中國中西醫結合雜誌(11)，1298-1307。
29.荀況、工天海校釋（2005）。苟子校釋.下冊。上海：上海古籍出版社。
30.徐凱（2016）。佛洛伊德、榮格與阿德勒的釋夢觀比較。心理技術與應用, 4(4), 245-249。
31.徐茂青、玄進、徐唱 & 吳逸南（2021） 。中醫從“雙心”理論治療冠狀動脈粥樣硬化性心臟病伴焦慮、抑鬱研究概況。山東中醫藥大學學報(06)，849-854。
32.王超、王昀、趙海濱（2016）。從中醫“雙心學說”探析冠心病合併焦慮的論治思路。環球中醫藥9(12)，1476-1478。
33.王曉寅（2014)。癌症病人夢的主題調查及意象工作療效研究。未出版碩士論文，華南師範大學，廣州。
34.楊扶國（2001）。齊南中醫藏象與臨床。北京：北京中醫古籍出版社。
35.楊韶剛（2002）。精神追求——神秘的榮格。哈爾濱：黑龍江出版社。
36.楊振寧（2009）。中醫藏象神志學說的心理學意義辨析。未出版碩士論文，山東師範大學。
37.于曉晗、李平（2019）。雙心醫學與氣絡學說對中醫“心主神明”論及其基礎研究的影響及作用探究。環球中醫藥(04)，537-539。
38.張伯華（1994）。中醫心理學。北京：科學出版社。
39.張會芳（2012）。團體心理輔導對冠心病患者焦慮、抑鬱情緒及自信心的影響。中國美容醫學。21(9):167-168。
40.朱文鋒 （1985）。中醫學對心理器官的認識。湖南中醫學院學報(02)，9-10。
41.Al-Qezweny, M. N. A., Utens, E. M.W. J., Dulfer, K., Hazemeijer, F., Van Geuns, R. J., & Daemen, J., et al. (2016). The association between type d personality, and depression and anxiety ten years after pci. Netherlands Heart Journal, 24(9), 538-543.
42.Ale,Intara C,Muntner P,&Edmondson D.Perfect storm:concurrent stress and depressive symptoms increase Risk of myocardial infarction or death .Circ Cardiovasc Qual Outcomes,2015,8(2):146-154.
43.Arnason, S., Zimmerman, L., Nieveen, J.Schulz, P.,& Young,L. (2012). Patient recovery and Cameron, L.D., & Leventhal, H.(2003).The self-regulation of health and illness behaviour. London: Routledge.
44.Astin, F., Closs, S.J., McLenachan. J, Hunter, S., & Priestley, C. (2009). Primary angioplasty for heart attack: Mismatch between expectations and reality? Journal of Advanced Nursing, 65(1).72-83.
45.Aydin Sunbul, E., Sunbul, M., Gulec H. (2017).The impact of major depression on heart rate variability and endothelial dysfunction in patients with stable coronary artery disease .Gen Hosp Psychiatry.44:4-9.
46.Baldacchino, D. (2010). Long-term causal meaning of myocardial infarction. British Journal ofNursing,19(12), 774-781.
47.Banason, S., Zimmerman, L., Nieveen, J.Schulz, P.,& Young,L. (2012). Patient recovery and transitions after hospitalization for acute cardiac events:An integrative review. Journal of Cardiovascular Nursing,27(2),175-191.
48.Barth, J., Schumacher, M., & Herrmann-Lingen, C. (2004). Depression as a risk factor for mortality in patients with coronary heart disease:A meta-analysis. Psychosomatic Medicine,66(6),802-813.
49.Barton, D. A., Dawood, T., Lambert, E. A., Esler, M.D, Haikerwal, D., Brenchley,C.,Hickie,I(2007).Sympathetic activity in major depressive disorder: identifying those at increased cardiac risk? Journal of Hypertension,25(10),2117-2124.
50.Bauer, G.P., &Kobos,J.C.Kobos, J, C. (1993). Brief therapy: Short-terms psychodynamic intervention. Northvale, NJ: Jason Aronson.
51.Beach,S.R.,Celano,C.M., Noseworthy,P.A., Januzzi,J.L&Huffman, J.C.(2013). QTc prolongation, torsades de pointes, and psychotropic medications. Psychosomatics, 54( 1), 1-13.
52.Berkman, 1.F., Blumenthal,J., Burg, M., Carney,R. M., Catellier, D., Cowan, M.J,Schneiderman, N. (2003). Effects of treating depression and low perceived social support on clinical events after myocardial infarction: The Enhancing Recovery in Coronary Heart Disease Patients (ENRICHD) randomized trial. JAMA, 289(23), 3106-3116.
53.Bonetti, P.O., Lerman, L. O.,& Lerman,A. (2002). Endothelial dysfunction: A marker of atherosclerotic risk. Arteriosclerosis Thrombosis and Vascular Biology,22,1065-1074.
54.Bosnak, R. (2007). Embodiment: Creative imagination in medicine, art and travel. London:Routledge, 29-36.
55.Bosnak, R. (1997). Christopher’s Dreams: Dreaming and Living With AIDS.UK; Delta, 1997:66-89.
56.Bot,M.,Carney,R,M.,Freedland,K.E.,Rubin,E.H.,Rich,M.W.,Steinmeyer, B.C.,&Mann,D.L. (2011). Infammation and treatment response to sertraline in patients with coronary heart disease and comorbid major depression. Journal of Psychosomatic Research,71(1),13-17.
57.Bulkeley,K.(2010).Dreaming as inspiration: evidence from religion, philosophy,literature,and film. International Review of Neurobiology,92(3 1-46).
58.Burg,M.M.,Martens,E.J.,Collins,D.,&Soufer,R.(2011). Depression predicts elevated endothelin-1 in patients with coronary artery disease.Psychosomatic Medicine,73(1),2.
59.Calogeras,R.C., & Alston,T.M.(2000).The dreams of a cancer patient: a "royal road" to understanding the somatic illness. Psychoanalytic review, 87(6), 911.
60.Carney,R..(2001). Depression hearth rate variability, and acute myocardial infarction. Circulation, 104.
61.Carney, R. M; Blumenthal.9,A:Freedland-K. E., Stein, P.K., Howells, W B.,Berkman, L. F,Watkins, L.L., Czajkowski- S. M., Hayano, J., Domitrovich, P. P.,& Jaffe,A.S. (2005). Low heart rate variability and the effect of depression on post-myocardial infarction mortality. Archives of Internal Medicine. 165,1486-1491.
62.Carney, R.M., Freedland, K.E., Stein, P. K. , Skala, J. A., Hoffman, P., & Jaffe, A.S.(2000). Change in heart rate and heart rate variability during treatment for depression in patients with coronary heart disease. Psychosomatic Medicine, 62(5), 639.
63.Cartwright, R.D. (2010). The twenty-four hour mind: The role of sleep and dreaming in our emotional lives (PP.37-38).New York,NY:Oxford University Press.
64.Cartwright, R.D. (2008).The contribution of the psychology of sleep and dreaming to understanding sleep-disordered patients. Sleep Medicine Clinics,3(2),157-166.
65.Cavalcanti-Ribeiro,P.,Andrade-Nascimento,M.,Morais-de-Jesus,M., Melquiades de Medeiros,Daltro-Oliveira,R.,Oliveira Conceicao,J.,& Castro Quarantini,l. (2012). Post-traumatic stress disorder as a comorbidity: Impact on disease outcome. Expert Review Neurotherapy,12(8),1023-1037.
66.Cogar,M.C.&Hill,C.E.(1992).Examming the effects of brief individual dream interpretation.Dreaming,2,239-248.
67.Colquhoun, D.M.,Bunker,S.J.,Clark,D.M., Glozier,N., Hare, D. L., Hickie,I. B., Branagan,l.G. (2013). Screening, referral and treatment for depression in patients with coronary heartdisease: A consensus statement from the National Heart Foundation of Australia. Medical Journal of Australia, 198(9).
68.Cooper, D, C., Tomfohr, L. M., Milic, M. S., Natarajan, L., Bardwell, W. A., Ziegler, M.G., &Dimsdale, J. E. (2011). Depressed mood and flow-mediated dilation: A systematic review and meta-analysis. Psychosomatic Medicine, 73,360-369.
69.Daban, C., Vieta, E., Mackin, P., & Young, A.H. (2005). Hypothalamic-pituitary-adrenal axis and bipolar disorder. Psychiatric Clinics of North America,28,469.69-480.
70.Denollet, J., Conraads, V.M., Brutsaert, D. L., Clerck, L., Stevens, W. J., & Vrints, C.J. (2003). Cytokines and immune activation in systolic heart failure: the role of type d personality. Brain Behavior & Immunity, 17(4), 304-309.
71.Denollet, J., de Jonge, P., Kuyper, A., Schene, A. H., van Melle, J. P.,Ormel, J.,et al. (2009).Depression and Type D personality re-present different forms of distress in the Myocardial Infarction and Defsion-Intervention Trial(MIND-IT).Psychological Medicine,39 (5),749-756.
72.Denollet, J., Sys,S.U., &Brutsaert, D.L. (1995). Personality and mortality after myocardial infarction. Psychosomatic Medicine,57(6) ,582-591.
73.Denollet, J., &Brutsaert, D.L. (2001). Reducing emotional distress Improves prognosis in coronary heart disease. Circulation, 104, 2018-2023.
74.Domash,L. (2016). Dreamwork and transformation: Facilitating therapeutic change using embodied imagination. Contemporary Psychoanalysis, 52(3), 410-433.
75.Driessen E., Cuijpers P., de Maat SCM., Abbass AA., & de Jonghe F. (2010). The efficacy of short-term psychodynamic psychotherapy for depression: a meta-analysis, Clin Psychol Rev,30 (1) : 25-36.
76.Du J., Zhang D., &Yin Y.(2016). The Personality and Psychological Stress Predict Major Adverse Cardiovascular Events in Patients With Coronary Heart Disease After Percutaneous Coronary Intervention for Five Years. Medicine, 95(15):e3364.
77.Edelman,S., Lemon, J., & Kidman, A..(2003). The perceived benefits of a group cbt intervention for patients with coronary heart disease. Journal of Cognitive Psychotherapy, 17(1), 59-65.
78.Ffrasure-Smith, L..(2007). Effects of citalopram and interpersonal psychotherapy on depression in patients with coronary artery disease: the canadian cardiac randomized evaluation of antidepressant and psychotherapy efficacy (create) trial. Digest of the World Core Medical Journals.
79.Flosnak, R (1997). Christopher’s Dreams: Dreaming and Living With AIDS.UK: Delta.66 -89.
80.Frasure-Smith, N., & Lesperance,F. (2005). Reflections on depression as a cardiac risk factor. Psychosomatic Medicine,67(Supplement l), S19-S25.
81.Frasure-Smith,N.,Lesperance,F.,Gravel.G.,Masson,A.,Juneau,M.,Talajic, M.,&Bourassa,M.G.(2000).Social support,depression,and mortality during the first year after myocardial infarction. Circulation.101,1919-1924.
82.Freud,s.(1917).Mourning and melancholia.In J.Strackey(Ed.), The standard edition of thecomplete psychological works of Sigmund Freud (pp.243-258). London: Hogarth Press.
83.Garganeeva N.,&Belokrylova M. (2017). Features of coronary heart disease course in patients with depressive disorders. European Psychiatry. 41:235.
84.Glassman, Alexander, H., O'Connor, Christopher, & M., et al. (2002). Sertraline treatment of major depression in patients with acute mi or unstable angina. JAMA Journal of the American Medical Association. 288(6):701-709.
85.Glucksman, M. L., & Kramer, M. (2004). Using dreams to assess clinical change during treatment. Journal of the American Academy of Psychoanalysis & Dynamic Psychiatry, 32(2), 345-358.
86.Glucksman.M.L. (1988).The use of successive dreams to facilitate and document change during treatment.Journal of the American Academy ofPsychoanalysis,16(1),47-70.
87.Grace, S.L., Abbey, S.E., Pinto, R., Shnek, Z. M, Irvine, J., & Stewart, D. E.(2005).Longitudinal course of depressive symptomatology after a cardiac event: Effects of gender and cardiac Medicine, 67(1), 52-58.
88.Grippo, A. J., & Johnson, A. K. (2002). Biological mechanisms in the relationship betweendepression and heart disease. Neuroscience& Biobehavioral Reviews,26, 941_962.
89.Malpas, S. C. (2010). Sympathetic nervous system over activity ,and its role in the development of ardiovascular disease. Physiological Reviews, 90, 513-557.
90.Groleau, D., Whitley, R., Lesperance, F, & Kirmayer, L.J. (2010). Spiritual reconfigurations of self after a myocardial infarction: Influence of culture and place. Health & Place, 16(5),853-860.
91.Hare, D. L., Toukhsati, S. R., Johansson, P., & Jaarsma, T. (2013). Depression and cardiovascular disease: A clinical review. European Heart Journal.
92.Hasnain, M., Vieweg, W.V. R., Lesnefsky, E.J.,Pandurangi,A.K.(2011). Depresssion,creening in patients with coronary heart disease: A critical evaluation of the AHA guidelines.Journal of Psychosomatic Research, 71, 6-12.
93.Higgins,R.O.,Murphy, B. M., Nicholas, A.,Worcester, M.U.,&Lindner.H. (2007). Emotionaland adjustment issues faced by cardiac patients seen in clinical practice: A qualitative survey oi;perienced clinicians. Journal of Cardiopulmonary Rehabilitation ana Prevention,27(5),291-297.
94.Hill, C. E. (1996a). Dreams and therapy. Psychotherapy Research, 6(1), 1-15.
95.Hill, C. E. (1996b). Working with dreams in psychotherapy. New York: Guilford Press.
96.Hill, C. E. (2004). Dream work in therapy: Facilitating exploration, insight, and action. Washington: American Psychological Association.
97.Hill, C.E., & Goates, M.K. (2004). Research on the Hill cognitive-experimential dream model. In C.E.Hill (Ed.), Dream work in therapy. Washington: American Psychological Association.
98.Hill,C.E.,&Knox,S.(2010).The use of dreams in modern psychotherapy. International Review of Neurobiology,92(92),291-317.
99.Hill, C.E., Diemer, R., & Heaton, K.J. (1997). Dream interpretation sessions: Who volunteers, who benefits, and what volunteer clients view as most and least helpful. Journal of Counseling Psychology, 44.
100.Hill, C.E., Rochlen, A.B., Zack, J.S., McCready, T., & Dematitis, A. (2003). Working with dreams using the Hill Cognitive-Experiential Model:A comparison of computer-assisted, therapist empathy, and therapist empathy+input conditions.Journal of Counseling Psychology, 50, 211-220.
101.Horwitz, A.V., &Wakefield, J. (2007). The loss of sadness:How psychiatry transformednormal sorrow into depressive disorder. New York: Oxford University Press.
102.Jane, R., Ski, C.F., Thompson, D.R., & Reza, B.H. (2013). Psychological interventions for patients with coronary heart disease and their partners: a systematic review. Plos One, 8(9), e73459.
103.Jiang, W., Krishnan, R.R., & O’Connor, C.M. (2002). Depression and heart disease: Evidence ofa link, and its therapeutic implications. CNS Drugs, 16(2), 111-127.
104.Jung, C.G. (1974). Dreams. Princeton,NJ:Princeton University Press.
105.Katon, W.J; Lin.E.H, Russo, J., Von Korff M.- Ciechanowski, P., Simon, G.,, Young, B.(2004). Cardiac risk factors in patients with diabetes mellitus and major depression. Journal of General Internal Medicine.19(12), 1192-1199.
106.Kemp, A. H; Quintana, D.S., Gray, M. A., Felmingham, K. L., Brown, K.db GaJ.M. (2010).Impact of depression and antidepressant treatment on heart rate variability: A review and meta-analysis. Biological Psychiatry,67,1067-1074.
107.Kerr,E.E.,& Fothergill-Bourbonnais, F. (2002). The recovery mosaic: Older women’s lived experiences after a myocardial infarction. Heart & Lung, 31(5), 355-367.
108.King, D.B. (2006). New support for the continuity hypothesis of dreaming. Paper presented at the 23rd Annual Conference of the International Association for the Study of Dreams, Bridgewater,MA.
109.Kirschner N.(1999). Changes in dream content after drug treatment. Dreaming, 9:195-200.
110.Kop, W.J., &Gottdiener, J.S. (2005). The role of immune system parameters in the relationship between depression and coronary artery disease. Psychosomatic Medicine. 67, S37-S41.
111.Krippner, S., Bogzaran, F., &Carvalho, A.P.D. (2002). Review of extraordinary dreams and how to work with them. Journal of Parapsychology, 66(4), 416-419.
112.Lange-Asschenfeldt, C., & Lederbogen, F. (2011). Antidepressant therapy in coronary arterydisease. Der Nervenarzt, 82(5), 657-664. Quiz 665-656.
113.Lara-Carrasco,J., Nielsen,T.A., Solomonova,E., Levrier,K.,&Popova,A. (2009). Overnight emotional adaptation to negative stimuli is altered by REM sleep deprivation and is correlated with intervening dream emotions.Sleep Research,18,178-187.
114.Lesperance, F., Frasure-Smith N., Juneau, M., &Theroux,P. (2000). Depression and l-year prognosis in unstable angina. Archives of Internal Medicine,160(9),1354-1360.
115.Lesperance F, Frasure-Smith N.(2007). Depression and heart disease[J]. Cleve Clin J Med 74(Suppl 1):S63-S66.
116.Lichtman, J.H., Froelicher, E.S., Blumenthal,J A., Carney, R.M., Doering, L. V, Frasure-Smith,N,Stroke Nursing. (2014). Depression as arisk factor for poor prognosis among patients with acute coronary syndrome: Systematic review and recommendations: A scientific state-ment from the American Heart Association. Circulation, 129(12),
117.Lichtman,J.H., Froelicher,E.S., Blumenthal,J. A., Carney,R. M., Doering,L. V., Frasure-Smith,N., Wulsin, L. (2014). Depression as a risk factor for poor prognosis among patients withacute coronary syndrome: Systematic review and recommendations: A scientific statementrom the American Heart Association. Circulation, 129(12), 1350-69.
118.Lloyd, A. (1989). Evolution and the interpretation of dreams. Ethology & Sociobiology, 10(5), 411-411.
119.Mallik, S., Krumholz, H.M., Lin, Z.Q-, Kasl,S.V., Mattera,J.A., Roumains, S.A.,& Vaccarino. (2005). Patients with depressive symptoms have lower health status benefits after coronaryartery bypass surgery. Circulation, 111(3), 271-277.
120.Matthias M, Perikles S, & Tommaso G.(2013). Psychodynamic motivation and training program (pmt) for the secondary prevention in patients with stable coronary heart disease: study protocol for a randomized controlled trial of feasibility and effects. Current Controlled Trials in Cardiovascular Medicine,14.
121.MD Hopkinson, Reavell, J., Lane, D.A. , &Mallikarjun,P.(2019). Cognitive behavioral therapy for depression, anxiety, and stress in caregivers of dementia patients: a systematic review and meta-analysis. Gerontologist(4).
122.Merrill, S.&Cary.G.L.(1975). Dream analysis in brief psychotherapy. American Journal of Psychotherapy, 29,185-192.
123.Mlesser, S.B.,&Warren,C.S.(1995). Models of brief psychodynamictherapy. NewYork: Guilford Press.
124.Murphy,B.M., Elliott,P.C., Higgins,R.O., Le Grande, M.R., Worcester, M.U.,Goble,A.J.,&Tatoulis,J.(2008a). Anxiety and depression after coronary artery bypass graft surgery: Mostget better, some get worse. European.lournal of Cardiovascular Prevention and Rehabilitation,15(4), 434-440.
125.Murphy, B.M., Rogerson, M., Worcester, M.U.C., Elliott, P.C.,Higgins,R.O., Le Grande,M. R., Goble, A.(2013). Predicting mortality 12 years after an acute cardiac event: Comparison between in-hospital and 2-month assessment of depressive symptoms invomen. Journal of Cardiopulmonary Rehabilitation and Prevention, 33,160-167.
126.Musselman, D.L., Tomer, A., Manatunga,A.K., Knight,B.T., Porter, M.R., Kasey,S., Nemeroff, C.B. (1996). Exaggerated platelet reactivity in major depression. [Research Suport, Non-U.S. Gov’t Research Support, U.S. Gov’t, P.H.S.l. American Journal of Psychiatry,153(10), 1313-1317.71(2), 61_68 .
127.Nyklicek,I., Dijksman, S.C., Lenders,P.J.Fonteijn,WA.,dc Koolen, J.J. (2014). A briefmindfulness based intervention for increase in emotional well-being and quality of life in percutaneous coronary intervention (PCI) patients: The mindful Heart randomized controlled, trial. Journal of Behavioral Medicine,37(1),135-144.
128.Pedersen, S.S., Denollet, J., Ong, A., Serruys, P.W., Erdman, R.,& Domburg, R.(2007). Impaired health status in type d patients following pci in the drug-eluting stent era. International Journal of Cardiology, 114(3), 358-365.
129.Pelle, A.J., Schiffer, A.A., Smith,O.R., Widdershoven, J.W., & Denollet, J.. (2010). Inadequate consultation behavior modulates the relationship between type d personality and impaired health status in chronic heart failure. International Journal of Cardiology, 142(1), 65-71.
130.Perls,E(1969). Gestalt therapy verbatim. (New York:Bantam)
131.Pries, A.R., Badimon, L., Bugiardini, R., Camici, P. G. , Dorobantu, M., & Duncker, D.J., et al. (2015). Coronary vascular regulation, remodelling, and collateralization: mechanisms and clinical implications on behalf of the working group on coronary pathophysiology and microcirculation. European Heart Journal(45), 3134-46.
132.Robert Bosnak.(2007). Embodiment: Creative imagination in Medicine, Art and travel. Routledge.
133.Richard Kradin.(2008). The placebo response and the power of unconscious healing. Taylor &Francis group, LLC.:101-169.
134.Richards, S.H., Anderson, L., Jenkinson, C.E., Whalley, B., & Taylor, R.S.(2018).Psychological interventions for coronary heart disease. Cochrane database of systematic reviews. Eur J Prev Cardiol,25 (3):247-259.
135.Roncella,A.,Pristipino,C.,Cianfrocca,C.,Scorza,S.,Pasceri,V.,Pelliccia,F.,…Speciale,G.(2013). One-year results of the randomized, controlled, short-term psychotherapy in acute. ocardial infarction (STEP-IN-AMI) trial. International Journal of Cardiology, 170(2),132-139.
136.Rucińska, Z., Fondelli, T., & Gallagher, S. (2021, February). Embodied imagination and metaphor use in autism spectrum disorder. In Healthcare (Vol. 9, No. 2, p. 200). MDPI.
137.Sanner, J.E., & Frazier, L. (2011). The role of serotonin in depression and clotting in the coronary artery disease population. Journal of Cardiovascular Nursing, 26(5), 423-429.
138.Schiffer, A.A., Denollet, J.,Widdershoven, J.W., Hendriks, E.H., & Smith, O.(2007). Failure to consult for symptoms of heart failure in patients with a type-d personality. Heart:official journal of the British Cardiac Society.
139.Schrader, G., Cheok. F., Hordacre, A.L., & Guiver, N. (2004). Predictors of depression three months after cardiac hospitalization. Psychosomatic Medicine, 66(4), 514-520.
140.Schredl,M., &Erlacher,D.(2007). Self-reported effects of dreams on waking-life creativity: an empirical study.PsychoL 141,35-46.
141.Shahar, G., & Lerman, S.F. (2012). The personification of chronic physical illness: its role in adjustment and implications for psychotherapy integration. Journal of Psychotherapy Integration, 23(1), 49-58.
142.Thombs,B.D., Bass,E.B., Ford,D.E., Stewart,k.J., Tsilidis,K.K., Patel, U., Ziegelstein,R.C. (2006). Prevalence of depression in survivors of acute myocardial infarction: Review of evidence. Journal of General Internal Medicine,21,30-38
143.Trivedi, M.H., Greer, T.L., Church, T.S. , Carmody, T.J., & Blair, S.N. (2011). Exercise as an augmentation treatment for nonremitted major depressive disorder: a randomized, parallel dose comparison. J Clin Psychiatry, 72(5), 677-684.
144.TuLly, P.J., & Baker,R.A.(2012). Depression,anxiety, and cardiac morbidity outcomes after coronary artery bypass surgery: A contemporary and practical review. Journal of GeriatricCardiology,9,197-208.
145.Ullman,M.(1996). Appreciating dreams: A group approach. Thousand Oaks: Sage Publications, Inc.
146.Ullman, M., & Limmer, C.(Eds.). (1987). The variety of dream experience: Expanding our ways of working with dreams. New York: Continuum.
147.White, J. L. (2015). From reliving to relieving: Using embodied imagination to help veterans move forward. Journal of Humanistic Psychology, 55(2), 247-260
148.Whooley, M.A., &Wong,J,M.(2013). Depression and cardiovascular disorders. Annual Review of Clinical Psychology,9,327-354.
149.Zuidersma, M., Thombs, B.D., & de Jonge, P. (2011). Onset and recurrence of depression asredictors of cardiovascular prognosis in depressed acute coronary syndrome patients: A systematic review. Psychotherapy and Psycho-somatics,80(4),227-237.
150.Wamsley, E.J., &Stickgold, R.(2011). Memory,sleep and dreaming: experiencing consolidation.Journal of Clinical Sleep Medicine,6,97-108.
151.Williams L., &Wingate A. (2012). Type D personality, physical symptoms and subjective stress: The mediating effects of coping and social support. Psychology & Health. 27(9):1075-1085.
2.蔡琴鳳、李曉駟（2010）。 夢的內容分析理論研究進展。安徽醫學，31(6)，687-689。
3.陳光磊、黃濟民(2006)。混沌理論對心理諮詢與治療的啟示。教育評論(3),3。
4.陳侃（譯）（2007）。探索夢的原野。廣州：廣東教育出版社（Bosnak, R., 1996）。
5.陳侃(2012)。現代人的心理危機及其幹預的心理分析。上海：上海三聯書店。
6.陳侃（2013）。意象體現與物化體驗。意象體現與中國文化（188–208 頁），廣州：洗心島出版社。
7.車文博（2004）。佛洛伊德·精神分析導論。長春：長春出版社。
8.陳韜、姚祖培（2014）。姚祖培教授辨治“雙心”疾病經驗。中醫藥通報13（1），35-36。
9.笛卡爾（1997）。哲學著作。巴黎：伽爾尼耶出版社。
10.杜瑞霞（2013）．夢的研究進展．語文學刊(6)，76-77，98。
11.馮川（譯）（1987）。榮格心理學入門。上海：上海三聯書店。（霍爾·諾貝德，1987）。
12.馮強、趙旭東(2011)。精神動力學心理治療的效果。上海精神醫學(05)，307-311。
13.高春申（譯）（2013）。夢的解析。北京：中華書局。（Freud, S., 1900）。
14.胡大一（2006）。心血管疾病和精神心理障礙的綜合管理——“雙心醫學”模式的探索。中國臨床醫生34（5），2-3。
15.胡孚深、呂錫（1999）。探道學通論。北京：社會科學文獻出版社。
16.胡孚深、呂錫深（1999）。道學通論(道家道教仙學)。北京：社會科學文獻出版社。
17.李曉紅、張巍、趙明、張紅斌(2011)。冠心病合併不同程度抑鬱患者心率變異性分析。中國心血管雜誌(06)，425-427。
18.李小平(2006)。混沌理論的心理治療觀。南京師大學報(社會科學版)(01)，103-106。
19.羅建平 (1996)。無意識心理學與中醫精神學。醫古文知識(02)，8-10。
20.劉韻涵（譯）（1988）。榮格分析心理學導論。瀋陽：遼寧人民出版。 （弗爾達姆）。
21.呂偉紅(2010)。比較分析佛洛伊德和榮格的釋夢。學術交流(10), 18-21.
22.樸順天（2002）。心神理論研究。未出版博士論文，北京中醫藥大學，北京。
23.申荷永（2001）。中國文化心理學心要。北京：人民出版社。
24.申荷永（2004）。榮格與分析心理學。廣州：廣東高等教育出版。
25.申荷永（2011）。 洗心島之夢。廣州：廣東科技出版社。
26.申荷永（2013）。意象體現與中國文化。廣州：洗心島出版社。
27.申荷永、高嵐（譯）（2014）。榮格文集Ⅳ/Ⅴ（夢的分析）。長春：長春出版社。（Jung, C. G.）。
28.世界中醫藥聯合會心血管病專業委員會、中國中西醫結合學會心血管病專業委員會、中華中醫藥學會介入心臟病學會、國家中醫心血管病臨床醫學研究中心（2020）。冠狀動脈血運重建術後心絞痛中西醫結合診療指南。中國中西醫結合雜誌(11)，1298-1307。
29.荀況、工天海校釋（2005）。苟子校釋.下冊。上海：上海古籍出版社。
30.徐凱（2016）。佛洛伊德、榮格與阿德勒的釋夢觀比較。心理技術與應用, 4(4), 245-249。
31.徐茂青、玄進、徐唱 & 吳逸南（2021） 。中醫從“雙心”理論治療冠狀動脈粥樣硬化性心臟病伴焦慮、抑鬱研究概況。山東中醫藥大學學報(06)，849-854。
32.王超、王昀、趙海濱（2016）。從中醫“雙心學說”探析冠心病合併焦慮的論治思路。環球中醫藥9(12)，1476-1478。
33.王曉寅（2014)。癌症病人夢的主題調查及意象工作療效研究。未出版碩士論文，華南師範大學，廣州。
34.楊扶國（2001）。齊南中醫藏象與臨床。北京：北京中醫古籍出版社。
35.楊韶剛（2002）。精神追求——神秘的榮格。哈爾濱：黑龍江出版社。
36.楊振寧（2009）。中醫藏象神志學說的心理學意義辨析。未出版碩士論文，山東師範大學。
37.于曉晗、李平（2019）。雙心醫學與氣絡學說對中醫“心主神明”論及其基礎研究的影響及作用探究。環球中醫藥(04)，537-539。
38.張伯華（1994）。中醫心理學。北京：科學出版社。
39.張會芳（2012）。團體心理輔導對冠心病患者焦慮、抑鬱情緒及自信心的影響。中國美容醫學。21(9):167-168。
40.朱文鋒 （1985）。中醫學對心理器官的認識。湖南中醫學院學報(02)，9-10。
41.Al-Qezweny, M. N. A., Utens, E. M.W. J., Dulfer, K., Hazemeijer, F., Van Geuns, R. J., & Daemen, J., et al. (2016). The association between type d personality, and depression and anxiety ten years after pci. Netherlands Heart Journal, 24(9), 538-543.
42.Ale,Intara C,Muntner P,&Edmondson D.Perfect storm:concurrent stress and depressive symptoms increase Risk of myocardial infarction or death .Circ Cardiovasc Qual Outcomes,2015,8(2):146-154.
43.Arnason, S., Zimmerman, L., Nieveen, J.Schulz, P.,& Young,L. (2012). Patient recovery and Cameron, L.D., & Leventhal, H.(2003).The self-regulation of health and illness behaviour. London: Routledge.
44.Astin, F., Closs, S.J., McLenachan. J, Hunter, S., & Priestley, C. (2009). Primary angioplasty for heart attack: Mismatch between expectations and reality? Journal of Advanced Nursing, 65(1).72-83.
45.Aydin Sunbul, E., Sunbul, M., Gulec H. (2017).The impact of major depression on heart rate variability and endothelial dysfunction in patients with stable coronary artery disease .Gen Hosp Psychiatry.44:4-9.
46.Baldacchino, D. (2010). Long-term causal meaning of myocardial infarction. British Journal ofNursing,19(12), 774-781.
47.Banason, S., Zimmerman, L., Nieveen, J.Schulz, P.,& Young,L. (2012). Patient recovery and transitions after hospitalization for acute cardiac events:An integrative review. Journal of Cardiovascular Nursing,27(2),175-191.
48.Barth, J., Schumacher, M., & Herrmann-Lingen, C. (2004). Depression as a risk factor for mortality in patients with coronary heart disease:A meta-analysis. Psychosomatic Medicine,66(6),802-813.
49.Barton, D. A., Dawood, T., Lambert, E. A., Esler, M.D, Haikerwal, D., Brenchley,C.,Hickie,I(2007).Sympathetic activity in major depressive disorder: identifying those at increased cardiac risk? Journal of Hypertension,25(10),2117-2124.
50.Bauer, G.P., &Kobos,J.C.Kobos, J, C. (1993). Brief therapy: Short-terms psychodynamic intervention. Northvale, NJ: Jason Aronson.
51.Beach,S.R.,Celano,C.M., Noseworthy,P.A., Januzzi,J.L&Huffman, J.C.(2013). QTc prolongation, torsades de pointes, and psychotropic medications. Psychosomatics, 54( 1), 1-13.
52.Berkman, 1.F., Blumenthal,J., Burg, M., Carney,R. M., Catellier, D., Cowan, M.J,Schneiderman, N. (2003). Effects of treating depression and low perceived social support on clinical events after myocardial infarction: The Enhancing Recovery in Coronary Heart Disease Patients (ENRICHD) randomized trial. JAMA, 289(23), 3106-3116.
53.Bonetti, P.O., Lerman, L. O.,& Lerman,A. (2002). Endothelial dysfunction: A marker of atherosclerotic risk. Arteriosclerosis Thrombosis and Vascular Biology,22,1065-1074.
54.Bosnak, R. (2007). Embodiment: Creative imagination in medicine, art and travel. London:Routledge, 29-36.
55.Bosnak, R. (1997). Christopher’s Dreams: Dreaming and Living With AIDS.UK; Delta, 1997:66-89.
56.Bot,M.,Carney,R,M.,Freedland,K.E.,Rubin,E.H.,Rich,M.W.,Steinmeyer, B.C.,&Mann,D.L. (2011). Infammation and treatment response to sertraline in patients with coronary heart disease and comorbid major depression. Journal of Psychosomatic Research,71(1),13-17.
57.Bulkeley,K.(2010).Dreaming as inspiration: evidence from religion, philosophy,literature,and film. International Review of Neurobiology,92(3 1-46).
58.Burg,M.M.,Martens,E.J.,Collins,D.,&Soufer,R.(2011). Depression predicts elevated endothelin-1 in patients with coronary artery disease.Psychosomatic Medicine,73(1),2.
59.Calogeras,R.C., & Alston,T.M.(2000).The dreams of a cancer patient: a "royal road" to understanding the somatic illness. Psychoanalytic review, 87(6), 911.
60.Carney,R..(2001). Depression hearth rate variability, and acute myocardial infarction. Circulation, 104.
61.Carney, R. M; Blumenthal.9,A:Freedland-K. E., Stein, P.K., Howells, W B.,Berkman, L. F,Watkins, L.L., Czajkowski- S. M., Hayano, J., Domitrovich, P. P.,& Jaffe,A.S. (2005). Low heart rate variability and the effect of depression on post-myocardial infarction mortality. Archives of Internal Medicine. 165,1486-1491.
62.Carney, R.M., Freedland, K.E., Stein, P. K. , Skala, J. A., Hoffman, P., & Jaffe, A.S.(2000). Change in heart rate and heart rate variability during treatment for depression in patients with coronary heart disease. Psychosomatic Medicine, 62(5), 639.
63.Cartwright, R.D. (2010). The twenty-four hour mind: The role of sleep and dreaming in our emotional lives (PP.37-38).New York,NY:Oxford University Press.
64.Cartwright, R.D. (2008).The contribution of the psychology of sleep and dreaming to understanding sleep-disordered patients. Sleep Medicine Clinics,3(2),157-166.
65.Cavalcanti-Ribeiro,P.,Andrade-Nascimento,M.,Morais-de-Jesus,M., Melquiades de Medeiros,Daltro-Oliveira,R.,Oliveira Conceicao,J.,& Castro Quarantini,l. (2012). Post-traumatic stress disorder as a comorbidity: Impact on disease outcome. Expert Review Neurotherapy,12(8),1023-1037.
66.Cogar,M.C.&Hill,C.E.(1992).Examming the effects of brief individual dream interpretation.Dreaming,2,239-248.
67.Colquhoun, D.M.,Bunker,S.J.,Clark,D.M., Glozier,N., Hare, D. L., Hickie,I. B., Branagan,l.G. (2013). Screening, referral and treatment for depression in patients with coronary heartdisease: A consensus statement from the National Heart Foundation of Australia. Medical Journal of Australia, 198(9).
68.Cooper, D, C., Tomfohr, L. M., Milic, M. S., Natarajan, L., Bardwell, W. A., Ziegler, M.G., &Dimsdale, J. E. (2011). Depressed mood and flow-mediated dilation: A systematic review and meta-analysis. Psychosomatic Medicine, 73,360-369.
69.Daban, C., Vieta, E., Mackin, P., & Young, A.H. (2005). Hypothalamic-pituitary-adrenal axis and bipolar disorder. Psychiatric Clinics of North America,28,469.69-480.
70.Denollet, J., Conraads, V.M., Brutsaert, D. L., Clerck, L., Stevens, W. J., & Vrints, C.J. (2003). Cytokines and immune activation in systolic heart failure: the role of type d personality. Brain Behavior & Immunity, 17(4), 304-309.
71.Denollet, J., de Jonge, P., Kuyper, A., Schene, A. H., van Melle, J. P.,Ormel, J.,et al. (2009).Depression and Type D personality re-present different forms of distress in the Myocardial Infarction and Defsion-Intervention Trial(MIND-IT).Psychological Medicine,39 (5),749-756.
72.Denollet, J., Sys,S.U., &Brutsaert, D.L. (1995). Personality and mortality after myocardial infarction. Psychosomatic Medicine,57(6) ,582-591.
73.Denollet, J., &Brutsaert, D.L. (2001). Reducing emotional distress Improves prognosis in coronary heart disease. Circulation, 104, 2018-2023.
74.Domash,L. (2016). Dreamwork and transformation: Facilitating therapeutic change using embodied imagination. Contemporary Psychoanalysis, 52(3), 410-433.
75.Driessen E., Cuijpers P., de Maat SCM., Abbass AA., & de Jonghe F. (2010). The efficacy of short-term psychodynamic psychotherapy for depression: a meta-analysis, Clin Psychol Rev,30 (1) : 25-36.
76.Du J., Zhang D., &Yin Y.(2016). The Personality and Psychological Stress Predict Major Adverse Cardiovascular Events in Patients With Coronary Heart Disease After Percutaneous Coronary Intervention for Five Years. Medicine, 95(15):e3364.
77.Edelman,S., Lemon, J., & Kidman, A..(2003). The perceived benefits of a group cbt intervention for patients with coronary heart disease. Journal of Cognitive Psychotherapy, 17(1), 59-65.
78.Ffrasure-Smith, L..(2007). Effects of citalopram and interpersonal psychotherapy on depression in patients with coronary artery disease: the canadian cardiac randomized evaluation of antidepressant and psychotherapy efficacy (create) trial. Digest of the World Core Medical Journals.
79.Flosnak, R (1997). Christopher’s Dreams: Dreaming and Living With AIDS.UK: Delta.66 -89.
80.Frasure-Smith, N., & Lesperance,F. (2005). Reflections on depression as a cardiac risk factor. Psychosomatic Medicine,67(Supplement l), S19-S25.
81.Frasure-Smith,N.,Lesperance,F.,Gravel.G.,Masson,A.,Juneau,M.,Talajic, M.,&Bourassa,M.G.(2000).Social support,depression,and mortality during the first year after myocardial infarction. Circulation.101,1919-1924.
82.Freud,s.(1917).Mourning and melancholia.In J.Strackey(Ed.), The standard edition of thecomplete psychological works of Sigmund Freud (pp.243-258). London: Hogarth Press.
83.Garganeeva N.,&Belokrylova M. (2017). Features of coronary heart disease course in patients with depressive disorders. European Psychiatry. 41:235.
84.Glassman, Alexander, H., O'Connor, Christopher, & M., et al. (2002). Sertraline treatment of major depression in patients with acute mi or unstable angina. JAMA Journal of the American Medical Association. 288(6):701-709.
85.Glucksman, M. L., & Kramer, M. (2004). Using dreams to assess clinical change during treatment. Journal of the American Academy of Psychoanalysis & Dynamic Psychiatry, 32(2), 345-358.
86.Glucksman.M.L. (1988).The use of successive dreams to facilitate and document change during treatment.Journal of the American Academy ofPsychoanalysis,16(1),47-70.
87.Grace, S.L., Abbey, S.E., Pinto, R., Shnek, Z. M, Irvine, J., & Stewart, D. E.(2005).Longitudinal course of depressive symptomatology after a cardiac event: Effects of gender and cardiac Medicine, 67(1), 52-58.
88.Grippo, A. J., & Johnson, A. K. (2002). Biological mechanisms in the relationship betweendepression and heart disease. Neuroscience& Biobehavioral Reviews,26, 941_962.
89.Malpas, S. C. (2010). Sympathetic nervous system over activity ,and its role in the development of ardiovascular disease. Physiological Reviews, 90, 513-557.
90.Groleau, D., Whitley, R., Lesperance, F, & Kirmayer, L.J. (2010). Spiritual reconfigurations of self after a myocardial infarction: Influence of culture and place. Health & Place, 16(5),853-860.
91.Hare, D. L., Toukhsati, S. R., Johansson, P., & Jaarsma, T. (2013). Depression and cardiovascular disease: A clinical review. European Heart Journal.
92.Hasnain, M., Vieweg, W.V. R., Lesnefsky, E.J.,Pandurangi,A.K.(2011). Depresssion,creening in patients with coronary heart disease: A critical evaluation of the AHA guidelines.Journal of Psychosomatic Research, 71, 6-12.
93.Higgins,R.O.,Murphy, B. M., Nicholas, A.,Worcester, M.U.,&Lindner.H. (2007). Emotionaland adjustment issues faced by cardiac patients seen in clinical practice: A qualitative survey oi;perienced clinicians. Journal of Cardiopulmonary Rehabilitation ana Prevention,27(5),291-297.
94.Hill, C. E. (1996a). Dreams and therapy. Psychotherapy Research, 6(1), 1-15.
95.Hill, C. E. (1996b). Working with dreams in psychotherapy. New York: Guilford Press.
96.Hill, C. E. (2004). Dream work in therapy: Facilitating exploration, insight, and action. Washington: American Psychological Association.
97.Hill, C.E., & Goates, M.K. (2004). Research on the Hill cognitive-experimential dream model. In C.E.Hill (Ed.), Dream work in therapy. Washington: American Psychological Association.
98.Hill,C.E.,&Knox,S.(2010).The use of dreams in modern psychotherapy. International Review of Neurobiology,92(92),291-317.
99.Hill, C.E., Diemer, R., & Heaton, K.J. (1997). Dream interpretation sessions: Who volunteers, who benefits, and what volunteer clients view as most and least helpful. Journal of Counseling Psychology, 44.
100.Hill, C.E., Rochlen, A.B., Zack, J.S., McCready, T., & Dematitis, A. (2003). Working with dreams using the Hill Cognitive-Experiential Model:A comparison of computer-assisted, therapist empathy, and therapist empathy+input conditions.Journal of Counseling Psychology, 50, 211-220.
101.Horwitz, A.V., &Wakefield, J. (2007). The loss of sadness:How psychiatry transformednormal sorrow into depressive disorder. New York: Oxford University Press.
102.Jane, R., Ski, C.F., Thompson, D.R., & Reza, B.H. (2013). Psychological interventions for patients with coronary heart disease and their partners: a systematic review. Plos One, 8(9), e73459.
103.Jiang, W., Krishnan, R.R., & O’Connor, C.M. (2002). Depression and heart disease: Evidence ofa link, and its therapeutic implications. CNS Drugs, 16(2), 111-127.
104.Jung, C.G. (1974). Dreams. Princeton,NJ:Princeton University Press.
105.Katon, W.J; Lin.E.H, Russo, J., Von Korff M.- Ciechanowski, P., Simon, G.,, Young, B.(2004). Cardiac risk factors in patients with diabetes mellitus and major depression. Journal of General Internal Medicine.19(12), 1192-1199.
106.Kemp, A. H; Quintana, D.S., Gray, M. A., Felmingham, K. L., Brown, K.db GaJ.M. (2010).Impact of depression and antidepressant treatment on heart rate variability: A review and meta-analysis. Biological Psychiatry,67,1067-1074.
107.Kerr,E.E.,& Fothergill-Bourbonnais, F. (2002). The recovery mosaic: Older women’s lived experiences after a myocardial infarction. Heart & Lung, 31(5), 355-367.
108.King, D.B. (2006). New support for the continuity hypothesis of dreaming. Paper presented at the 23rd Annual Conference of the International Association for the Study of Dreams, Bridgewater,MA.
109.Kirschner N.(1999). Changes in dream content after drug treatment. Dreaming, 9:195-200.
110.Kop, W.J., &Gottdiener, J.S. (2005). The role of immune system parameters in the relationship between depression and coronary artery disease. Psychosomatic Medicine. 67, S37-S41.
111.Krippner, S., Bogzaran, F., &Carvalho, A.P.D. (2002). Review of extraordinary dreams and how to work with them. Journal of Parapsychology, 66(4), 416-419.
112.Lange-Asschenfeldt, C., & Lederbogen, F. (2011). Antidepressant therapy in coronary arterydisease. Der Nervenarzt, 82(5), 657-664. Quiz 665-656.
113.Lara-Carrasco,J., Nielsen,T.A., Solomonova,E., Levrier,K.,&Popova,A. (2009). Overnight emotional adaptation to negative stimuli is altered by REM sleep deprivation and is correlated with intervening dream emotions.Sleep Research,18,178-187.
114.Lesperance, F., Frasure-Smith N., Juneau, M., &Theroux,P. (2000). Depression and l-year prognosis in unstable angina. Archives of Internal Medicine,160(9),1354-1360.
115.Lesperance F, Frasure-Smith N.(2007). Depression and heart disease[J]. Cleve Clin J Med 74(Suppl 1):S63-S66.
116.Lichtman, J.H., Froelicher, E.S., Blumenthal,J A., Carney, R.M., Doering, L. V, Frasure-Smith,N,Stroke Nursing. (2014). Depression as arisk factor for poor prognosis among patients with acute coronary syndrome: Systematic review and recommendations: A scientific state-ment from the American Heart Association. Circulation, 129(12),
117.Lichtman,J.H., Froelicher,E.S., Blumenthal,J. A., Carney,R. M., Doering,L. V., Frasure-Smith,N., Wulsin, L. (2014). Depression as a risk factor for poor prognosis among patients withacute coronary syndrome: Systematic review and recommendations: A scientific statementrom the American Heart Association. Circulation, 129(12), 1350-69.
118.Lloyd, A. (1989). Evolution and the interpretation of dreams. Ethology & Sociobiology, 10(5), 411-411.
119.Mallik, S., Krumholz, H.M., Lin, Z.Q-, Kasl,S.V., Mattera,J.A., Roumains, S.A.,& Vaccarino. (2005). Patients with depressive symptoms have lower health status benefits after coronaryartery bypass surgery. Circulation, 111(3), 271-277.
120.Matthias M, Perikles S, & Tommaso G.(2013). Psychodynamic motivation and training program (pmt) for the secondary prevention in patients with stable coronary heart disease: study protocol for a randomized controlled trial of feasibility and effects. Current Controlled Trials in Cardiovascular Medicine,14.
121.MD Hopkinson, Reavell, J., Lane, D.A. , &Mallikarjun,P.(2019). Cognitive behavioral therapy for depression, anxiety, and stress in caregivers of dementia patients: a systematic review and meta-analysis. Gerontologist(4).
122.Merrill, S.&Cary.G.L.(1975). Dream analysis in brief psychotherapy. American Journal of Psychotherapy, 29,185-192.
123.Mlesser, S.B.,&Warren,C.S.(1995). Models of brief psychodynamictherapy. NewYork: Guilford Press.
124.Murphy,B.M., Elliott,P.C., Higgins,R.O., Le Grande, M.R., Worcester, M.U.,Goble,A.J.,&Tatoulis,J.(2008a). Anxiety and depression after coronary artery bypass graft surgery: Mostget better, some get worse. European.lournal of Cardiovascular Prevention and Rehabilitation,15(4), 434-440.
125.Murphy, B.M., Rogerson, M., Worcester, M.U.C., Elliott, P.C.,Higgins,R.O., Le Grande,M. R., Goble, A.(2013). Predicting mortality 12 years after an acute cardiac event: Comparison between in-hospital and 2-month assessment of depressive symptoms invomen. Journal of Cardiopulmonary Rehabilitation and Prevention, 33,160-167.
126.Musselman, D.L., Tomer, A., Manatunga,A.K., Knight,B.T., Porter, M.R., Kasey,S., Nemeroff, C.B. (1996). Exaggerated platelet reactivity in major depression. [Research Suport, Non-U.S. Gov’t Research Support, U.S. Gov’t, P.H.S.l. American Journal of Psychiatry,153(10), 1313-1317.71(2), 61_68 .
127.Nyklicek,I., Dijksman, S.C., Lenders,P.J.Fonteijn,WA.,dc Koolen, J.J. (2014). A briefmindfulness based intervention for increase in emotional well-being and quality of life in percutaneous coronary intervention (PCI) patients: The mindful Heart randomized controlled, trial. Journal of Behavioral Medicine,37(1),135-144.
128.Pedersen, S.S., Denollet, J., Ong, A., Serruys, P.W., Erdman, R.,& Domburg, R.(2007). Impaired health status in type d patients following pci in the drug-eluting stent era. International Journal of Cardiology, 114(3), 358-365.
129.Pelle, A.J., Schiffer, A.A., Smith,O.R., Widdershoven, J.W., & Denollet, J.. (2010). Inadequate consultation behavior modulates the relationship between type d personality and impaired health status in chronic heart failure. International Journal of Cardiology, 142(1), 65-71.
130.Perls,E(1969). Gestalt therapy verbatim. (New York:Bantam)
131.Pries, A.R., Badimon, L., Bugiardini, R., Camici, P. G. , Dorobantu, M., & Duncker, D.J., et al. (2015). Coronary vascular regulation, remodelling, and collateralization: mechanisms and clinical implications on behalf of the working group on coronary pathophysiology and microcirculation. European Heart Journal(45), 3134-46.
132.Robert Bosnak.(2007). Embodiment: Creative imagination in Medicine, Art and travel. Routledge.
133.Richard Kradin.(2008). The placebo response and the power of unconscious healing. Taylor &Francis group, LLC.:101-169.
134.Richards, S.H., Anderson, L., Jenkinson, C.E., Whalley, B., & Taylor, R.S.(2018).Psychological interventions for coronary heart disease. Cochrane database of systematic reviews. Eur J Prev Cardiol,25 (3):247-259.
135.Roncella,A.,Pristipino,C.,Cianfrocca,C.,Scorza,S.,Pasceri,V.,Pelliccia,F.,…Speciale,G.(2013). One-year results of the randomized, controlled, short-term psychotherapy in acute. ocardial infarction (STEP-IN-AMI) trial. International Journal of Cardiology, 170(2),132-139.
136.Rucińska, Z., Fondelli, T., & Gallagher, S. (2021, February). Embodied imagination and metaphor use in autism spectrum disorder. In Healthcare (Vol. 9, No. 2, p. 200). MDPI.
137.Sanner, J.E., & Frazier, L. (2011). The role of serotonin in depression and clotting in the coronary artery disease population. Journal of Cardiovascular Nursing, 26(5), 423-429.
138.Schiffer, A.A., Denollet, J.,Widdershoven, J.W., Hendriks, E.H., & Smith, O.(2007). Failure to consult for symptoms of heart failure in patients with a type-d personality. Heart:official journal of the British Cardiac Society.
139.Schrader, G., Cheok. F., Hordacre, A.L., & Guiver, N. (2004). Predictors of depression three months after cardiac hospitalization. Psychosomatic Medicine, 66(4), 514-520.
140.Schredl,M., &Erlacher,D.(2007). Self-reported effects of dreams on waking-life creativity: an empirical study.PsychoL 141,35-46.
141.Shahar, G., & Lerman, S.F. (2012). The personification of chronic physical illness: its role in adjustment and implications for psychotherapy integration. Journal of Psychotherapy Integration, 23(1), 49-58.
142.Thombs,B.D., Bass,E.B., Ford,D.E., Stewart,k.J., Tsilidis,K.K., Patel, U., Ziegelstein,R.C. (2006). Prevalence of depression in survivors of acute myocardial infarction: Review of evidence. Journal of General Internal Medicine,21,30-38
143.Trivedi, M.H., Greer, T.L., Church, T.S. , Carmody, T.J., & Blair, S.N. (2011). Exercise as an augmentation treatment for nonremitted major depressive disorder: a randomized, parallel dose comparison. J Clin Psychiatry, 72(5), 677-684.
144.TuLly, P.J., & Baker,R.A.(2012). Depression,anxiety, and cardiac morbidity outcomes after coronary artery bypass surgery: A contemporary and practical review. Journal of GeriatricCardiology,9,197-208.
145.Ullman,M.(1996). Appreciating dreams: A group approach. Thousand Oaks: Sage Publications, Inc.
146.Ullman, M., & Limmer, C.(Eds.). (1987). The variety of dream experience: Expanding our ways of working with dreams. New York: Continuum.
147.White, J. L. (2015). From reliving to relieving: Using embodied imagination to help veterans move forward. Journal of Humanistic Psychology, 55(2), 247-260
148.Whooley, M.A., &Wong,J,M.(2013). Depression and cardiovascular disorders. Annual Review of Clinical Psychology,9,327-354.
149.Zuidersma, M., Thombs, B.D., & de Jonge, P. (2011). Onset and recurrence of depression asredictors of cardiovascular prognosis in depressed acute coronary syndrome patients: A systematic review. Psychotherapy and Psycho-somatics,80(4),227-237.
150.Wamsley, E.J., &Stickgold, R.(2011). Memory,sleep and dreaming: experiencing consolidation.Journal of Clinical Sleep Medicine,6,97-108.
151.Williams L., &Wingate A. (2012). Type D personality, physical symptoms and subjective stress: The mediating effects of coping and social support. Psychology & Health. 27(9):1075-1085.
